Skip to content
    CollabAI
    PharmaAI
    PharmaAI by CollabAI · Drug Safety

    AI That Catches Adverse Events Before They Become Crises

    PharmacovigilanceAI reviews incoming AE reports, auto-codes to MedDRA, screens for safety signals via SMQ clustering, and routes critical events to your safety officer — with full ICH E2B(R3) audit trail.

    ICH E2B(R3) MedDRA v27.x FDA MedWatch HIPAA 21 CFR Part 11
    48hr → 4hr
    AE Processing Time
    100%
    Cases Auto-Coded
    0
    Missed SMQ Signals

    The Pharmacovigilance Problem

    Manual AE coding takes days

    A single serious adverse event report requires 4–6 hours of manual MedDRA coding, narrative writing, and E2B submission preparation. At 50 reports/month, that's 200–300 hours.

    SMQ signal detection is reactive

    Drug safety teams discover pharmacovigilance signals in aggregate reports — weeks after individual cases accumulate. AI screens every case in real-time.

    E2B submission errors cause rejection

    Manual ICH E2B(R3) XML generation is error-prone. Rejected submissions require rework cycles that delay safety reporting to regulators.

    How It Works

    From raw AE report to EudraVigilance-ready submission in minutes.

    1

    AE Report Intake

    Structured and unstructured sources — call transcripts, emails, forms.

    2

    MedDRA Auto-Coding

    Verbatim term → PT/HLT/HLGT/SOC with confidence score.

    3

    SMQ Screening

    Checks 100+ Standardised MedDRA Queries for safety signal clusters.

    4

    Causality Assessment

    WHO-UMC scale assessment, automated narrative drafting.

    5

    E2B(R3) XML Export

    Ready for EMA/FDA EudraVigilance submission.

    See the Drug Safety Workspace

    pharmacovigilance.ai/intake
    DEMO
    3 serious · 8 moderate · 22 mild this week
    ID
    Source
    Patient
    Drug
    Event
    Severity
    Status
    AE-2047
    Call Transcript
    PT-2047
    DrugX 50mg
    Headache
    MILD
    AUTO-CODED
    AE-2046
    Email
    PT-1893
    DrugX 50mg
    Palpitations
    MODERATE
    REVIEW
    AE-2045
    Web Form
    PT-3312
    DrugX 50mg
    Jaundice
    SERIOUS
    URGENT
    pharmacovigilance.ai/signals
    DEMO
    ⚠ Signal Detected: Hepatotoxicity SMQ
    3 cases in 30 days · Threshold exceeded
    📊 Monitoring: Cardiac Arrhythmias SMQ
    1 case · Below threshold
    ✓ Clear: Rhabdomyolysis SMQ
    0 cases
    Signal strength: MODERATE — Pharmacovigilance review required within 72h
    pharmacovigilance.ai/export/C-AE-2047
    DEMO
    MedDRA PT
    Headache (10019211)
    SOC
    Nervous system disorders
    Seriousness
    Non-serious
    Causality
    Possible
    Report Type
    Spontaneous
    E2B XML
    READY
    ICH E2B(R3) compliant · Validated schema

    Features

    Auto-coding with MedDRA v27.x

    SMQ cluster signal detection

    WHO-UMC causality assessment

    ICH E2B(R3) XML generation

    EudraVigilance integration

    21 CFR Part 11 audit trail

    Ready to modernize your drug safety operation?

    Cookie Settings

    We use cookies to enhance your experience, analyze site traffic and deliver personalized content. Privacy Policy.